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Dysregulated hippocampal neurogenesis has been associated with neurodegenerative disorders, including Alzheimer’s disease (AD), in
which it may potentially represent an auto-reparatory mechanism that could counteract neuronal loss and cognitive impairment. We
evaluated hippocampal neurogenesis in TgCRND8 mice and reported that, at 32 weeks of age, corresponding to an advanced AD-like
neuropathology stage, increased numbers of proliferating cells, doublecortin-expressing progenitors/neuroblasts, and early postmitotic
calretinin-expressing neurons were present compared with wild-type (WT) littermates. When hippocampal neural progenitor cells
(NPCs) were isolated fromTgCRND8mice, we demonstrated that (1) their neurogenic potential was higher comparedwithWTNPCs; (2)
medium conditioned by TgCRND8 NPC promoted neuronal differentiation of WT NPCs; and (3) the proneurogenic effect of TgCRND8-
conditioned medium was counteracted by blockade of the receptor for advanced glycation end products (RAGE)/nuclear factor-B
(NF-B) axis. Furthermore, we showed that -amyloid 1–42 (A1–42) oligomers, but not monomers and fibrils, and the alarmin high-
mobility group box-1 protein (HMGB-1) could promote neuronal differentiation of NPCs via activation of the RAGE/NF-B axis. Alto-
gether, these data suggest that, in AD brain, an endogenous proneurogenic response could be potentially triggered and involve signals
(A1–42 oligomers and HMGB-1) and pathways (RAGE/NF-B activation) that also contribute to neuroinflammation/neurotoxicity. A
more detailed analysis confirmed no significant increase of new mature neurons in hippocampi of TgCRND8 compared with WTmice,
suggesting reduced survival and/or integration of newborn neurons. Therapeutic strategies in AD should ideally combine the ability of
sustaininghippocampal neurogenesis aswell as of counteracting anhostile brainmicroenvironment so topromote survival of vulnerable
cell populations, including adult generated neurons.
Introduction
Receptor for advanced glycation end products (RAGE) is a
membrane-bound receptor activated by multiple ligands, includ-
ing advanced glycation end products, -amyloid (A) peptides
and oligomers, the alarmin high-mobility group box-1 protein
(HMGB-1), and calcium-binding proteins S100/calgranulins. In
the adult CNS, RAGE is expressed by several cell types, and, dur-
ing ligand binding, it produces a sustained cellular activation,
commonly regarded as deleterious because it participates in in-
flammation and cytotoxicity in both acute and chronic condi-
tions (Yan et al., 1996; Schmitt et al., 2006; Muhammad et al.,
2008; Han et al., 2011). Recently, a vast array of information has
raised attention on the potential contribution of RAGE to Alzhei-
mer’s disease (AD) pathophysiology. The expression levels of the
receptor and its ligands are indeed increased in AD brain (Sasaki
et al., 2001; Shuvaev et al., 2001; Takata et al., 2003; Lu¨th et al.,
2005; Shepherd et al., 2006; Gruden et al., 2007; Cruz-Sa´nchez et
al., 2010). Moreover, the expression of soluble RAGE isoforms,
which may act as decoy receptors, is reduced in brain and plasma
of AD patients with early cognitive deterioration (Nozaki et al.,
2007). According to the current knowledge, RAGE has been sug-
gested to play manifold roles in AD pathophysiology by increas-
ing A influx across the blood– brain barrier (Deane et al., 2004;
Silverberg et al., 2010; Mas´lin´ska et al., 2011), neuroinflamma-
tion (Du Yan et al., 1997; Lue et al., 2001; Fang et al., 2010),
A-induced oxidative stress (Takuma et al., 2009), and tau phos-
phorylation (Esposito et al., 2008; Li et al., 2012). In a mouse
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familial AD (FAD) model, RAGE overexpression was shown to
accelerate disease progression (Arancio et al., 2004).
Dysregulated adult hippocampal neurogenesis has also been
associated with several neurodegenerative disorders, including
AD (Bondolfi et al., 2002; Jin et al., 2004a,b; Lo´pez-Toledano and
Shelanski, 2004; Ziabreva et al., 2006; Heo et al., 2007; Chen et al.,
2008; Lo´pez-Toledano et al., 2010; Rodríguez and Verkhratsky,
2011). Although at present the contribution of hippocampal neu-
rogenesis to disease pathophysiology is uncertain (Chuang, 2010;
Crews et al., 2010), the formation of new neurons in hippocam-
pus (HP) may potentially represent an endogenous auto-
reparatory mechanism that could attenuate neuronal loss and
cognitive impairment associated with AD (Schaeffer et al., 2009;
DeCarolis and Eisch, 2010). Interestingly, RAGE appeared to be
expressed by bromodeoxyuridine (BrdU)-labeled cells in the
adult rat subgranular zone (SGZ) after chronic fluoxetine admin-
istration, a treatment promoting hippocampal neurogenesis
(Malberg et al., 2000; Manev et al., 2003). Moreover, intracere-
broventricular infusion of the RAGE ligand S100B enhanced hip-
pocampal neurogenesis and, in parallel, ameliorated cognitive
performance after traumatic brain injury (Kleindienst et al.,
2005). Altogether, these findings suggest that RAGE may poten-
tially regulate a proneurogenic response to brain injury in the
hippocampal area. This hypothesis is corroborated by previous
data demonstrating that activation of the RAGE/nuclear
factor-B (NF-B) axis promotes both proliferation and neuro-
nal differentiation of adult SVZ neural progenitor cells (NPCs) in
vitro (Meneghini et al., 2010).
Based on these observations, we decided to investigate the
putative role of the RAGE/NF-B axis in the modulation of adult
hippocampal neurogenesis and its potential relevance in AD
pathophysiology.
Materials andMethods
Animals. For in vivo studies, transgenic (Tg) (n  32) and wild-type
(WT) (n 30) mice of the TgCRND8 line (Chishti et al., 2001; Hyde et
al., 2005) were used at different age points, ranging from 8 to 32 weeks.
For in vitro studies, 4- to 6-month-old male CD1 mice, purchased from
Charles River Laboratories, 6-to 8-month-old male Tg and WT
TgCRND8 mice and 4-to 6-month-old NF-B p50/ (B6; 129P2-Nfb1
tm1 Bal/J ) and WT (B6; 129PF2) mice, obtained from The Jackson Lab-
oratory, were used. Mice, kept three to four per cage with access to water
and food ad libitum, were maintained in high-efficiency particulate air-
filtered Thoren units (Thoren Caging System) at the University of East-
ern Piedmont animal facility. Animal care and treatments were
performed in accordance with European Community Directive 86/609/
EEC guidelines and were reviewed and approved by the local Institu-
tional Animal Care and Use Committee.
Neuropathological assessment of TgCRND8 mice. Eight-, 15-, 25-, and
32-week-old TgCRND8 mice (three to six per group) and their age-
matched non-Tg littermates were used. Mice were transcardially per-
fused with saline first and then with 4% paraformaldehyde (PFA). After
removal, brains were postfixed and then washed with 0.01 M PBS, 50%
ethanol, and 70% ethanol, and finally stored in 70% ethanol at 4°C until
embedding processing. Brains were embedded in paraffin, and serial
sections were taken from the anterior pole to cerebellum with a mi-
crotome (Leica Lasertechnik) at 8m thickness. Sections were incubated
overnight at 4°C with primary antibodies. To identify A plaques and
astrogliosis, sections were incubated overnight at 4°C with a mouse
anti-A protein monoclonal antibody (1:100; Merck Millipore) and with
a mouse monoclonal antibody to glial fibrillary acidic protein (GFAP)
(1:50; Boehringer Mannheim), respectively. After washing in PBS, slides
were incubated with biotinylated horse anti-mouse antibody (1:200;
Vector Laboratories), followed by ABC reagent (Vector Laboratories) for
30 min at room temperature and developed using DAB peroxidase
(Sigma-Aldrich). Three slices per mouse at the level of the HP, each
separated by320 m, were used at each age for quantification. Immu-
nostained sections were acquired through a CCD video camera con-
nected to the microscope (10 objective for amyloid plaques and 20
for GFAP), and images were processed with a computerized image anal-
ysis system (Image Pro Plus software; Media Cybernetics), as described
previously (Hyde et al., 2005).
Immunohistochemistry analyses. Mice (n  5– 6 per group) were in-
jected with BrdU (150 mg/kg body weight, i.p.) and killed 24 h later.
Alternatively, mice were injected twice a day with BrdU (100 mg/kg body
weight, i.p.) for 5 consecutive days and killed 21 d after the last injection.
The following primary antibodies were used: rabbit polyclonal anti-
Sox-2 (SRY-related HMG-box gene 2) (1:800; Merck Millipore), goat
polyclonal anti-RAGE (1:800; R&D Systems), rat monoclonal anti-BrdU
(1:200; Novus Biologicals), rabbit polyclonal anti-doublecortin (DCX)
(1:200; Cell Signaling Technology), rabbit polyclonal anti-calretinin
(CR) (1:4000; Swant), and mouse monoclonal anti-NeuN antibody (1:
100; Merck Millipore). For quantification and phenotypic characteriza-
tion of newborn cells, a modified unbiased stereology protocol was used,
as described previously (Denis-Donini et al., 2008).
Isolation and culture of adult hippocampal neurospheres.For hippocam-
pal neurosphere (NS) preparation from adult mice, the detailed proce-
dure was as described previously (Denis-Donini et al., 2008). Primary
[passage 1 (P1)] NS were dissociated after 7 d in vitro, whereas P2–P30
NS were dissociated every 5 d in vitro. At each passage, cells were grown as
described previously (Denis-Donini et al., 2008). P3–P30 NS were used
in this study.
Preparation of A1–42 forms. Synthetic A1-42 peptide (Sigma-Aldrich)
was initially dissolved to 1 mM in hexafluoroisopropanol (Sigma-
Aldrich) and aliquoted in sterile microcentrifuge tubes. Hexafluoroiso-
propanol was removed under vacuum, and the peptide film was stored
dessicated at 20°C. For the aggregation protocol, the peptide was dis-
solved in dry dimethylsulfoxide (Sigma-Aldrich) at a concentration of 5
mM. For preparation of A oligomers and fibrils, the protocol developed
by Dahlgren et al. (2002) was adopted. Peptide preparations were char-
acterized by using Tris–tricine separation gels. For detection, proteins
were stained with Proteosilver Silver Stain kit (Sigma-Aldrich).
ELISA assay. Human A1-42 levels were quantified in conditioned me-
dium derived from WT and TgCRND8 NPC cultures by using the A42
Human ELISA kit (Invitrogen), in accordance with the instructions of
the manufacturer.
NPC differentiation. For NPC differentiation, the detailed procedure
was described previously (Meneghini et al., 2010). NPCs were treated in
the presence of 0.01–10 ng/ml HMGB-1 (Sigma-Aldrich), 100 –500 nM
A1– 42 forms, or vehicle for 24 h. For RAGE blockade, 60 min before
RAGE ligand or vehicle addition, 20 g/ml neutralizing polyclonal anti-
RAGE antibody (R&D System) or preimmune IgG was added to NPC
culture medium. For NF-B inhibition, 10 g/ml SN-50 peptide, 10
g/ml SN-50M inactive control, 3 M JSH-23 [4-methyl-N1-(3-
phenylpropyl)benzene-1,2-diamine], and 3 M SC-514 (3-amino-5-
thiophen-3-ylthiophene-2-carboxamide) (Calbiochem-Merck) were
added to NPC cultures 60 min before RAGE ligand or vehicle, as de-
scribed previously (Valente et al., 2012). After 24 h, cells were washed in
PBS and fixed by ice-cold 4% PFA for 20 min at room temperature for
subsequent immunofluorescent analysis. In each experiment, five fields
per well were counted using a fluorescent microscope with a 60 objec-
tive. For experiments based on media switch between differentiated WT
or TgCRND8 NPCs, conditioned media were collected and centrifuged
at 235 g for 10 min, and supernatants were stored at 4°C before use. All
experiments were run in triplicates by using different cell preparations
and repeated at least three times.
Assessment of cell viability. Necrosis evaluation in NPC cultures was
performed as described previously (Meneghini et al., 2010). For apoptosis
quantification, an in situ terminal deoxynucleotidyltransferase-mediated
dUTP nick-end labeling (TUNEL) assay was performed by the In Situ
Cell Death Detection kit (Roche Diagnostics), in accordance with the
instructions of the manufacturer. All experiments were run in triplicates
in different cell preparations and repeated at least three times.
Immunocytochemistry. After fixation, undifferentiated or differenti-
ated NPCs were washed three times in PBS and permeabilized in PBS
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containing 0.48% (v/v) Triton X-100. Permeabilization was omitted for
RAGE immunostaining. The detailed procedure was described previ-
ously (Meneghini et al., 2010). The following primary antibodies were
used: rabbit monoclonal anti-MAP-2 (1:600; Merck Millipore), mouse
monoclonal anti-GFAP (1:400; Merck Millipore), goat polyclonal anti-
RAGE (1:600; Merck Millipore), chicken polyclonal anti-nestin (1:4000;
Neuromics), rabbit polyclonal anti-Sox-2 (1:500; Merck Millipore), rab-
bit polyclonal anti-CR (1:500; Swant), rabbit polyclonal anti-p65 (1:500;
Santa Cruz Biotechnology), and rabbit monoclonal NG-2 (1:500; Merck
Millipore). Nuclei were counterstained with 0.8 ng/ml Hoechst diluted in
PBS. Fluorescent microscope or laser-scanning confocal microscope
were used for analysis. Adobe Photoshop CS (Adobe Systems) was used
for digital processing of the images. Only light intensity, brightness, and
contrast adjustments were applied to improve information.
Protein isolation and Western blot analyses. For protein isolation, tis-
sues and NS from adult CD1 mice were disrupted in lysis buffer, homog-
enates were incubated on ice for 60 min and centrifuged at 15700 g for
30 min at 4°C, and the supernatant was recovered. Western blot analysis
was performed as described previously (Meneghini et al., 2010).
Statistical analyses. For in vivoneurogenesis evaluation, statistical anal-
ysis was performed using the unpaired, two-sided t test comparison (Stu-
dent’s t test). For amyloid burden and astrogliosis quantification in
TgCRND8 mice, comparison among ages was performed by one-way
ANOVA, and data were expressed as mean  SEM values. For in vitro
experiments, data are reported as mean SEM, with at least three rep-
licates per group and analyzed by two-sided t test comparison (Student’s
t test). Statistical significance level was set for p values0.05.
Results
RAGE is expressed by nestin and Sox-2NPCs of adult
mouse HP
By Western blot analysis, different RAGE isoforms can be de-
tected using two antibodies recognizing N- or C-terminal
epitopes (Fig. 1A). In lung protein extracts, used as positive con-
trol, both antibodies identified three bands with apparent molec-
ular weight (MW) of 43, 54, and 57 kDa (Gefter et al., 2009).
Additionally, the N-terminus antibody revealed bands corre-
sponding to 48 and 70 kDa. Based on previous reports
(Harashima et al., 2006; Hudson et al., 2008; Gefter et al., 2009;
Kalea et al., 2009), the 54 kDa species is likely to correspond to
full-length RAGE (FL-RAGE), whereas the 48 and 70 kDa bands
may represent endogenous secretory RAGE (esRAGE) proteins
obtained by C-terminal cleavage, because they are not detected by
the C-terminal antibody. The 57 kDa band presumably corre-
sponds to xRAGE, a less characterized membrane-bound RAGE
isoform (Gefter et al., 2009). Based on the MW of human ho-
mologs of RAGE isoforms, we can suppose that the band around
43 kDa presumably represents the mouse RAGE_v18, homolog
of the human RAGE_v4 (Hudson et al., 2008; Kalea et al., 2009).
In protein extracts of HP and undifferentiated neural progenitors
growing in NS, we detected a band pattern mostly similar to that
observed in lung extracts and including the most characterized
FL-RAGE and esRAGE. In addition, the antibody recognizing the
C-terminal epitope revealed a band around 45 kDa only in HP
and NS protein extracts, which may potentially represent the
murine homolog of the human membrane-bound N-truncated
isoform, the MW of which is 42 kDa (Yonekura et al., 2003), but
was not detected by the antibody against N-terminal epitope.
Subsequent immunocytochemical analysis of hippocampal NS
demonstrated the presence of RAGE immunoreactivity in undif-
ferentiated progenitors (Fig. 1B,E), which are characterized by
the expression of the intermediate neurofilament nestin (Fig. 1C)
and the transcription factor Sox-2 (Fig. 1F). Double-
immunolabeling experiments confirmed colocalization of RAGE
with nestin (Fig. 1D) and Sox-2 (Fig. 1G) in adult hippocampal
neural progenitors. Finally, immunohistochemical analysis of the
adult HP of CD1 mice showed that a subpopulation of Sox-2-
expressing (Sox-2) neural stem/NPCs in the dentate gyrus
(DG) also coexpresses RAGE. In particular, RAGE immunoreac-
tivity mainly decorated the process that those cells project toward
the external part of the granular cell layer (GCL) (Fig. 1H).
RAGE activation promotes differentiation of adult
hippocampal NPCs toward the neuronal lineage
RAGE activation by different ligands, including HMGB-1, pro-
motes neuronal differentiation of adult SVZ-derived NPCs
(Meneghini et al., 2010). Therefore, we decided to evaluate whether
RAGE had a similar functional role in adult hippocampal NPCs.
After removal of growth factors from the culture medium,
adult NPCs stop dividing and differentiate onto laminin-coated
dishes. Double immunolabeling for markers of neurons
(MAP-2) and undifferentiated progenitor cells (nestin) was per-
formed to dissect in vitro the different stages of neuronal differ-
entiation of NPCs derived from the HP of adult CD1 mice
(Valente et al., 2012) in response to HMGB-1, a RAGE ligand.
After 24 h, a concentration-dependent increase in the percentage
of MAP-2/nestin immature neurons was observed in cells
treated with 0.01–10 ng/ml HMGB-1 with a maximal effect elic-
ited at 1 ng/ml (percentage of increase over vehicle-treated cells,
44.1  11.6%, p  0.01; Fig. 1I). In parallel, we observed a
concentration-dependent increase in the percentage of MAP-2/
nestin mature neurons in HMGB-1-treated cells, with a maxi-
mal effect elicited at the same concentration (percentage of
increase over vehicle-treated cells, 176.3  32.7%, p  0.001;
Fig. 1J). Similarly, HMGB-1 treatment increased the percentage
of CR postmitotic neurons compared with vehicle-treated cells
(p  0.01 at 1–10 ng/ml; Fig. 1K), further confirming the pro-
neurogenic effect of HMGB-1 on adult hippocampal NPCs.
HMGB-1 effects on glial differentiation were also evaluated by
antibodies directed against GFAP and NG-2, markers of astro-
cytes and oligodendrocyte precursors, respectively. In our exper-
imental conditions, 1 ng/ml HMGB-1 had no effect on GFAP
(vehicle, 6.64  1.05%; 1 ng/ml HMGB-1, 6.44  1.97%) and
NG-2 cell populations (vehicle, 14.68  3.60%; 1 ng/ml
HMGB-1, 17.47  2.69%). To investigate whether HMGB-1
could promote cell survival in addition to neuronal differentia-
tion, we analyzed both the number of apoptotic cells and the
amount of lactate dehydrogenase (LDH) released by necrotic
cells in the presence of HMGB-1 or vehicle. By TUNEL assay, no
difference was observed in the apoptotic rate in vehicle- versus
HMGB1-treated cells (Fig. 1L). Similarly, no difference in LDH
activity was detected at 1 ng/ml HMGB-1 (Fig. 1M), as well as
other HMGB-1 concentrations (data not shown). Finally, we
demonstrated that HMGB-1 effect on neuronal differentiation of
adult NPCs was RAGE mediated because the HMGB-1-induced
increase in the percentage of MAP-2/nestin mature neurons
(Fig. 1N), MAP-2/nestin immature neurons (Fig. 1O), and
CR postmitotic neurons (Fig. 1P) could be prevented in the
presence of a neutralizing anti-RAGE antibody but not by preim-
mune IgG (-RAGE  HMGB-1 vs HMGB-1: p  0.001, p 
0.01, and p 0.01 for MAP-2/nestin, MAP-2/nestin, and
CR cells, respectively). When applied alone, -RAGE had no
significant effect on NPC differentiation (Fig. 1N–P). Overall,
these data confirmed that, in vitro, HMGB-1 promoted neuronal
differentiation of adult hippocampal NPCs via RAGE activation.
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NF-B signaling is involved in HMGB-1-mediated neuronal
differentiation of adult hippocampal NPCs
NF-B signaling lies downstream of RAGE activation in several
cell types, including SVZ-derived adult NPCs (Li and Schmidt,
1997; Bierhaus et al., 2001; Meneghini et al., 2010). Additionally,
NF-B proteins are involved in the regulation of adult hippocam-
pal neurogenesis (Denis-Donini et al., 2008; Koo et al., 2010). For
these reasons, we decided to investigate the involvement of
NF-B activation in RAGE-mediated effects on adult hippocam-
pal NPCs.
NF-B p65 immunoreactivity can be detected in the cyto-
plasm of the majority of vehicle-treated hippocampal NPCs (Fig.
2A). Within 30 min after cell exposure to 1 ng/ml HMGB-1,
NF-B p65 nuclear translocation could be observed (Fig. 2B).
Furthermore, 3 M JSH-23, a cell-permeable selective blocker of
NF-B p65 nuclear translocation (IC50 7M), completely pre-
vented HMGB-1-mediated increase of both MAP-2/nestin
immature neurons (JSH-23  HMGB-1 vs HMGB-1: p  0.01;
Fig. 2C) and MAP-2/nestin mature neurons (JSH-23 
HMGB-1 vs HMGB-1: p  0.001; Fig. 2D). Similar results were
Figure 1. RAGE, expressed by adult hippocampal NPCs, mediates proneurogenic effects elicited by HMGB-1. A, Representative immunoblots confirming the presence of different RAGE isoforms
in extracts fromundifferentiatedneural progenitors grown inNS,HP, or lung (L) byusing twoantibodies (Ab) recognizingdifferentN- andC-terminal epitopes. Bands corresponding toRAGE-specific
isoforms aremarked.B–G, Representative fluorescentmicroscopy images of NS immunolabeledwith antibodies against RAGE (B, E, red), nestin (C, green), and Sox-2 (F, green). Themerged images
showed that RAGE immunoreactivity colocalized with nestin (D) and Sox-2 (G). Magnification, 600. Scale bar, 56.2m. H, Representative confocal microscopy image of the adult mouse DG
immunostainedwith antibodies against RAGE (green) and Sox-2 (red). SomeSox-2NPCs (indicated by arrowheads)were also positive for RAGE.MOL,Molecular layer.Magnification, 400. Scale
bar, 70 m. Inset, Higher magnification of a Sox-2/RAGE cell. I–K, Under differentiating conditions, 24 h treatment of adult hippocampal NPCs with 0.1–10 ng/ml HMGB-1 significantly
increased, in a concentration-dependent manner, the percentage of MAP-2/nestin (I ), MAP-2/nestin (J ), and CR (K ) cells compared with vehicle-treated cells. L, M, No significant
difference was observed between vehicle- or HMGB-1-treated cultures in the percentage of apoptotic nuclei (L) and in LDH activity in media (M ) of differentiated cell cultures.N–P, A neutralizing
anti-RAGE antibody (-RAGE, 20g/ml), but not preimmune IgG serum (IgG), abolished the proneurogenic effects of 1 ng/mlHMGB-1 onMAP-2/nestin (N ),MAP-2/nestin (O), and CR
(P) cells. I–P, Data represent the mean SEM of n 3 experiments, run in triplicates. *p 0.05, **p 0.01, ***p 0.001 versus vehicle (Student’s t test).
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obtained in the presence of 10 g/ml SN-50, a cell-permeable
peptide that inhibits NF-B p50 nuclear translocation (Lin et al.,
1995) [SN-50 HMGB-1 vs HMGB-1: p 0.01 and p 0.001
for MAP-2/nestin (Fig. 2C) and MAP-2/nestin (Fig. 2D)
cells, respectively]. Interestingly, when applied alone, SN-50 pep-
tide produced a statistically significant decrease in the percentage
of MAP-2/nestin mature neurons when compared with
vehicle-treated cells (p 0.05; Fig. 2D). As a negative control, 10
g/ml SN-50M inactive peptide (Lin et al., 1995) had no effect
alone or in the presence of HMGB-1 (Fig. 2C,D). Finally, SC-514,
a selective and reversible inhibitor of IB kinase 2 (IKK2) (IC50
3–12 M), completely prevented HMGB-1-mediated effect on
MAP-2/nestin immature neurons (SC-514  HMGB-1 vs
HMGB-1: p  0.01; Fig. 2C) and on MAP-2/nestin mature
neurons (SC-514HMGB-1 vs HMGB-1: p 0.001; Fig. 2D) at
a concentration of 3 M. At all tested concentrations, JSH-23,
SN-50, and SC-514 had no effect on the survival of NPCs or
their progeny when added alone or in the presence of
HMGB-1 (data not shown). To further confirm the involve-
ment of NF-B signaling, we isolated and expanded in vitro
hippocampal NPCs derived from adult p50/ mice and their
WT littermates. As expected, in WT NPCs, 24 h exposure to 1
ng/ml HMGB-1 significantly increased the number of both
MAP-2/nestin immature neurons (p  0.01; Fig. 2E) and
MAP-2/nestin mature neurons (p  0.001; Fig. 2F) com-
pared with vehicle-treated cells. Conversely, HMGB-1 had no
effect in p50/ NPCs (Fig. 2E,F). Interestingly, in vehicle-
treated conditions, we observed a reduced number of MAP-2/
nestin cells in p50/ compared with WT cultures (5.5  0.5
and 3.1  0.3% in WT and p50/ cultures, respectively; p 
0.05; Fig. 2F). Overall, these data demonstrated the involvement
of NF-B signaling in the proneurogenic effects of HMGB-1 on
adult hippocampal NPCs.
Increased cell proliferation, generation of newborn
neuroblasts, and postmitotic neurons in hippocampi of 32-
week-old TgCRND8mice
TgCRND8 mice represent a well-established disease model char-
acterized by an early onset and rapidly progressing AD-like pa-
thology (Chishti et al., 2001; Hyde et al., 2005). To confirm that
progression, heterozygous TgCRND8 mice and their WT litter-
mates were examined at four different ages, namely 8, 15, 25, and
32 weeks. The time course of amyloid burden in cortex and hip-
pocampi of TgCRND8 mice was quantified by computer-assisted
image analysis. An age-dependent increase in the percentage of
area occupied by plaques was observed, ranging from 0.01 
0.00% at 8 weeks to 3.75 0.14% at 32 weeks of age (Fig. 3A). A
statistically significant difference was reported in 25-week-old
TgCRND8 mice versus both 15-week-old (p 0.05) and 8-week-
old (p  0.01) animals and in 32-week-old versus all other ages
(p 0.001). In addition to A deposition, an inflammatory pro-
cess reminiscent of AD also occurs in TgCRND8 mice (Chishti et
al., 2001; Hyde et al., 2005). Immunostaining with a GFAP-
specific antibody indicated the presence of astrocytosis that pro-
gressively increased with age in cortex and HP of Tg mice (data
not shown). GFAP-positive cells, showing the typical morphol-
ogy of reactive astrocytes with large cell bodies and thick pro-
cesses, started to be detected at 25 weeks of age, and patches of
immunolabeled cells could be seen in the cortex, whereas at 32
weeks, astrocytic reaction was spread to the whole cortex and
hippocampi. Image analysis allowed to quantify the extension
and age progression of astrogliosis in TgCRND8 versus age-
matched WT controls (Fig. 3B). The percentage of area occupied
by GFAP-positive cells increased from 0.71 0.28 at 8 weeks, to
2.34 0.78 at 15 weeks, 9.76 2.01 at 25 weeks, and 36.19 2.47
at 32 weeks. A statistically significant difference was reported in
25-week-old TgCRND8 mice versus both 15-week-old (p 
Figure 2. NF-B signaling is involved in HMGB1-mediated neuronal differentiation of hippocampal NPCs. A, B, HMGB-1 induced nuclear translocation of NF-B p65 in adult hippocampal NPCs
under differentiating conditions. Confocal microscopy images showing cytoplasmatic or nuclear (indicated by arrows) NF-B p65 immunostaining. NPCs were exposed for 30 min to vehicle (A) or
1 ng/ml HMGB-1 (B). Magnification, 800. Scale bar, 37.5m. C, D, The inhibition of NF-B signaling activation by SN-50 peptide (10g/ml), JSH-23 (3M), and SC-514 (3M) completely
abolished the increase of MAP-2/nestin (C) and MAP-2/nestin (D) cells induced by 1 ng/ml HMGB-1. When applied alone, SN-50 peptide decreased the percentage of MAP-2/nestin
mature neurons compared with vehicle-treated cells. SN-50M (negative control peptide) did not counteract HMGB-1-mediated effect on NPC neuronal differentiation. Data represent themean
SEM of n 3 experiments, run in triplicates. *p 0.05, **p 0.01, ***p 0.001 versus vehicle (Student’s t test). E, F, Twenty-four hours of treatment of WT and NF-B p50/ hippocampal
NPCswith 1 ng/ml HMGB-1 or vehicle. Comparedwith vehicle, HMGB-1 significantly increased the percentage ofMAP-2/nestin (E) andMAP-2/nestin (F ) neurons inWT but not in NF-B
p50/ cultures. E, F, Data represent the mean SEM of n 3 experiments, run in triplicates. *p 0.05, **p 0.01, ***p 0.001 versus vehicle-treated WT cells (Student’s t test).
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0.05) and 8-week-old (p 0.01) animals
and in 32-week-old versus all other ages
(p  0.001). In brain of WT animals,
there was no age-dependent difference
in the percentage of area occupied by
GFAP-positive cells (Fig. 3B), being on
average 0.48  0.13%.
Based on these neuropathology find-
ings, we decided to focus subsequent anal-
ysis on the following age points: (1) 8
weeks, which we consider a pre-plaque
stage; and (2) 20 and 32 weeks, which we
refer to as initial and advanced stage of
amyloid pathology and neuroinflamma-
tion, respectively. In TgCRND8 mice and
their WT littermates, we initially evalu-
ated hippocampal cell proliferation at dif-
ferent ages. Eight-, 20-, and 32-week-old
TgCRND8 and WT mice were adminis-
tered BrdU (150 mg/kg, i.p.) and killed
24 h later. We then quantified BrdU-
immunoreactive (IR) cells in the SGZ and
GCL of both WT and TgCRND8 mice.
Regardless of age, as expected, BrdU-IR
cells were distributed throughout the neu-
rogenic area, with the large majority of
them being mainly located in the SGZ in
both WT (66 –76%) and Tg (65–70%)
mice. As shown in Figure 3, C, D, and I,
BrdU-IR cell counts were comparable in
the SGZ and GCL in 8-week-old Tg and
WT mice. No significant change could be
observed when the total number of
BrdU cells in the DG was evaluated.
Similar results were obtained in 20-week-
old mice of both genotypes (Fig. 3E,F,J).
Conversely, 32-week-old TgCRND8 mice
had significantly more BrdU-IR cells in
the SGZ compared with age-matched WT
mice (mean SD number, 132 67 and
261  116 in WT and TgCRND8 mice,
respectively; p 0.05;198% vs WT; Fig.
3G,H,K). No significant difference was
observed between 32-week-old WT and
TgCRND8 mice in the GCL region
(mean SD number, 61 68 and 133
92 in WT and Tg mice, respectively; p  0.152; Fig. 3K). When
cell counts in the entire DG were analyzed, an increased, although
not statistically significant, number of BrdU-IR cells was observed in
TgCRND8 mice compared with WT littermates (mean SD num-
ber, 193 126 and 395 185 in WT and Tg mice, respectively; p
0.052; Fig. 3K). Moreover, analysis of BrdU-IR cells in the DG of
8-, 20-, and 32-week-old mice revealed an age-dependent reduction
in the number of SGZ BrdU-positive cells in both genotypes (Fig.
3I–K), an observation consistent with previous data showing a
precocious age-related decline in murine hippocampal cell
proliferation (Seki and Arai, 1995). Overall, these results sug-
gested the occurrence of increased cell proliferation in the
SGZ, a region in which neural stem/NPCs lie and divide
(Rietze et al., 2000; Kempermann et al., 2003), of TgCRND8
mice at an advanced stage of amyloid pathology.
To understand whether increased cell proliferation in the SGZ
of 32-week-old TgCRND8 mice compared with WT littermates
had an impact on the generation of adult-born neuroblasts and
neurons in that area, we then quantified the total number of
hippocampal cells expressing the neuroblast marker DCX in mu-
tant and WT mice of that age. A significantly increased number of
DCX cells was found in TgCRND8 GCL compared with age-
matched WT mice (mean SD number, 266 70 and 616 344
in WT and Tg mice GCL, respectively, p 0.01; 417 139 and
532 282 in WT and Tg mice SGZ, respectively, p 0.30; 683
188 and 1148  610 in WT and Tg mice DG, respectively, p 
0.05; Fig. 4A). DCX is expressed by proliferating progenitor cells
and newly generated neuroblasts (Brown et al., 2003). For these
reasons, we determined the number of BrdU/DCX cells in
32-week-old animals that were killed 24 h after administration of
the thymidine analog. An increased number of DCX/BrdU
cells was reported in the SGZ and not in the GCL of TgCRND8
mice compared with age-matched WT controls (in the SGZ,
mean SD, 64 17 and 174 82 in WT and Tg mice, respec-
Figure 3. Increased cell proliferation in the SGZ of TgCRND8mice at an advanced stage of AD-like neuropathology (32weeks of
age). A, Quantification of amyloid burden in cortex/hippocampi of TgCRND8 mice at 8, 15, 25, and 32 weeks showed an age-
dependent increase in the area percentage occupied by plaques. A statistically significant difference was reported in 25-week-old
TgCRND8mice versus both 15-week-old ( p 0.05) and 8-week-old ( p 0.01) animals and in 32-week-old versus all other ages
( p 0.001). B, Quantification of the area percentage occupied by GFAP-positive cells demonstrated an age-dependent progres-
sion of astrogliosis in cortex of TgCRND8 versus age-matched WT controls. A statistically significant difference was reported in
25-week-old TgCRND8mice versus both 15-week-old ( p 0.05) and 8-week-old ( p 0.01) animals and in 32-week-old versus
all other ages ( p  0.001). In WT animals, there was no age-dependent difference in the percentage of area occupied by
GFAP-positive cells.A,B, Comparison amongageswas performedbyone-wayANOVA, anddatawere expressed asmean values
SEM. **p 0.01, ***p 0.001 versus 8-week-old TgCRND8mice; #p 0.05, ###p 0.001 versus 15-week-old TgCRND8mice;
§§§p 0.001 versus 25-week-old TgCRND8mice. C–H, Representative images of BrdU immunostaining in DG ofWT (C, E, G) and
TgCRND8 (D, F, H ) mice at 8 (C, D), 20 (E, F ), and 32 (G, H ) weeks of age, killed 24 h after thymidine analog administration.
Arrowheads indicated BrdU proliferating cells in the SGZ. Asterisks (H ) indicated A plaques. Magnification, 200. Scale bar,
50m. I–K, Quantification of BrdU-IR cells in the SGZ, GCL, and total DG of 8-week-old (I ), 20-week-old (J ), and 32-week-old (K )
mice revealed a statistically significant increase in the number of SGZ BrdU cells in 32-week-old TgCRND8 mice compared with age-
matchedWT littermates (K ). Data represent themean SD.n 5mice per group. *p 0.05 versusWTmice (Student’s t test).
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tively, p 0.05; in the GCL, mean SD, 30 36 and 68 37 in
WT and Tg mice, respectively, p 0.19; in the DG, mean SD,
94 44 and 242 101 in WT and Tg mice, respectively; p 0.05;
Fig. 4B). Altogether, these data also suggested an increased pro-
liferation rate in DCX NPCs/neuroblasts of TgCRND8 mice
compared with their WT counterpart. To evaluate whether sur-
vival and/or neuronal commitment of newly generated cells was
indeed increased in hippocampi of 32-week-old TgCRND8 mice,
an additional group of animals of both genotypes (n 5– 6) was
administered BrdU and killed 21 d later. When BrdU immuno-
reactivity was analyzed, as expected, IR cells appeared to be dis-
tributed in the DG, with the large majority of them being located
in the GCL in both WT (73%) and Tg (64%) mice. No significant
difference in the absolute number of surviving BrdU-IR cells
could be observed between WT and TgCRND8 mice (mean SD
number, 190.4 79.3 and 379 269 in WT and Tg mice GCL,
respectively; p 0.170). Additionally, we evaluated the number
of DCX/BrdU cells in the hippocampi of 32-week-old
TgCRND8 and WT mice. A significantly increased number of
DCX/BrdU cells was present in the GCL of TgCRND8 versus
WT mice (mean SD, 35 23 and 86 43 in WT and Tg mice,
respectively; p  0.036; Fig. 4C). Overall, these data suggested
that an increased number of BrdU-labeled cells had indeed ac-
quired a DCX phenotype in TgCRND8 mice compared with
WT controls. CR is a calcium-binding protein transiently ex-
pressed at an early postmitotic stage by adult generated DG gran-
ule cells (Brandt et al., 2003). Counting of CR cells also revealed
a striking difference in the DG of 32-week-old TgCRND8 mice
compared with age-matched WT littermates. Significantly more
CR cells were indeed present in the SGZ, GCL, and DG of
TgCRND8 compared with age-matched WT mice (mean SD
number, 734  236 and 1578  476 in WT and Tg mice SGZ,
respectively, p  0.05, 115% vs WT control; 454  111 and
1386  600 in WT and Tg mice GCL, respectively, p  0.05,
205% vs WT control; 1188 317 and 2964 618 in WT and
Tg mice DG, respectively, p  0.01; 149% vs WT control;
Fig. 4D).
Overall, these data suggested that, at an advanced stage of AD-
like neuropathology, TgCRND8 mice displayed an increased num-
ber of hippocampal proliferating cells,
DCX proliferating progenitors/neuro-
blasts, and CR postmitotic neurons
compared with their age-matched WT
littermates.
Increased in vitro neurogenic potential
of adult hippocampal NPCs derived
from TgCRND8mice compared with
theirWT-derived counterpart: role of
A1–42 oligomers and RAGE/NF-B
axis activation
We then decided to isolate and culture hip-
pocampal NPCs derived from 32-week-old
WT and TgCRND8 mice. Under differenti-
ating conditions, we observed that, similarly
to what reported in vivo, TgCRND8 NPCs
gave rise to a significantly higher percentage
of CR postmitotic neurons compared
with WT NPCs (44.12.5 and 56.61.9%
in WT and TgCRND8 cultures, respectively;
28% vs WT NPCs; p 0.001; Fig. 5A–C).
Under the same experimental conditions,
no significant difference was observed in cell
death rate of WT versus TgCRND8-derived NPCs and their prog-
eny, as evaluated by TUNEL assay (Fig. 5D) or by measuring LDH
activity in the culture medium (data not shown). Interestingly, in the
presence of 20 g/ml -RAGE neutralizing antibody (Fig. 5E) and
10g/ml SN-50 peptide (Fig. 5F), the in vitro neurogenic potential
of TgCRND8 NPCs was reduced and similar to that of WT NPC.
Overall, these data confirmed that activation of the RAGE/NF-B
axis was involved in the increased neurogenic potential of
TgCRND8-derived hippocampal NPCs compared with their
WT counterpart.
We then collected conditioned media from TgCRND8 and
WT NPC cultures. When WT NPCs were exposed for 24 h to
TgCRND8-conditioned medium, a significantly higher number
of CR cells was counted compared with WT NPCs differenti-
ated in standard medium or WT NPC-conditioned medium
(p  0.01; Fig. 5G). Conversely, when TgCRND8 NPCs were
differentiated in the presence of conditioned medium from WT
cells, no difference was observed in the number of CR neurons
compared with TgCRND8 cells differentiated in standard me-
dium or in TgCRND8 NPC-conditioned medium (Fig. 5G).
These data suggested that soluble factors potentially released by
TgCRND8-derived NPCs could contribute to increased neuronal
differentiation in vitro. Finally, we evaluated, by immunofluores-
cence, p65 nuclear translocation in WT NPCs exposed for 2 h to
standard, TgCRND8-conditioned or WT-conditioned medium.
Under these experimental conditions, the percentage of cells with
p65 nuclei over the total number of p65-labeled cells significantly
increased in WT NPCs treated with TgCRND8-conditioned me-
dium compared with cultures exposed to WT-conditioned or stan-
dard medium (31.63 2.42, 19.13 1.64, and 19.12 1.23% in
TgCRND8-, WT-conditioned, and standard media, respectively;
p 0.01; Fig. 5H). To further confirm the role of NF-B signaling
pathway activation, we exposed WT NPCs to Tg-conditioned or
standard media in the presence of 3M JSH-23 or vehicle. Inhibition
of p65 nuclear translocation significantly reduced the effect of
Tg-conditioned medium on the number of CR cells [vehicle
(TgCRND8-conditioned medium) vs JSH23 (TgCRND8-
conditioned medium): p  0.01; Figure 5I]. As shown previously,
JSH-23 alone had no effect on WT NPC cultures (Fig. 5I). We then
Figure 4. TgCRND8 neural progenitors generate an increased number of DCX neuroblasts and CR postmitotic neu-
rons in vivo. A, Quantification of DCX-IR cells in SGZ, GCL, and DG of 32-week-old WT and TgCRND8 mice revealed a
significantly increased number in the GCL and DG of TgCRND8mice compared with their WT littermates. B, C, Quantification
of DCX/BrdU cells in 32-week-old WT and TgCRND8 mice killed 24 h (B) and 21 d (C) after BrdU injection. D, Quanti-
tative analysis of CR-IR cells in the SGZ, GCL, and total DG of 32-week-old mice revealed a significantly increased number in
all hippocampal subregions TgCRND8 mice compared with WT littermates. A–D, Data represent the mean number SD.
*p 0.05, **p 0.01 versus WT mice (Student’s t test).
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evaluated, by ELISA, the presence of A1–42
species in the conditioned media from
TgCRND8 and WT-derived NPC cul-
tures. Interestingly, A1– 42 could be de-
tected in medium that was conditioned
by TgCRND8-derived NPCs under dif-
ferentiating conditions (60.30  11.28
pg/ml), whereas, as expected, no detectable
amounts were present in WT-conditioned
media.
Based on these results, we treated WT
NPC cultures for 24 h with different con-
centrations (100 –500 nM) of A1– 42
monomers, oligomers, or fibrils, whose
nature was confirmed by running onto
Tris–tricine gels (Fig. 6A). Interestingly,
A1– 42 oligomers significantly increased,
in a concentration-dependent manner,
the percentage of CR postmitotic neu-
rons (Fig. 6B), MAP-2/nestin imma-
ture neurons (Fig. 6C), and MAP-2/
nestin mature neurons (Fig. 6D)
generated by WT NPCs when compared
with vehicle. Maximal effect by A1–42 oli-
gomers was elicited at 200 nM (percentage of
increase over vehicle-treated cells:53.5
5.2% CR cells, p  0.01; 33.1  8.8%
MAP-2/nestin cells, p 0.01;166.8
29.6% MAP-2/nestin cells, p  0.001).
Conversely, neither A1–42 monomers nor
A1–42 fibrils had positive effects on neuro-
nal differentiation of WT NPC (Fig. 6B–D).
Interestingly, 500 nM A1–42 fibrils signifi-
cantly decreased the percentage of MAP-
2/nestin mature neurons compared
with vehicle-treated cells (Fig. 6D,p0.05),
whereas it had no effect on CR and MAP-
2/nestin cells (Fig. 6B,C). Under the
same experimental conditions, no differ-
ence was observed between vehicle- and
A1–42-treated cultures in the apoptotic
(Fig. 6E) or necrotic (Fig. 6F) rate. Again, in
WT NPCs, 20 g/ml -RAGE antibody, 3
M JSH-23, and 10g/ml SN-50, but not 10
g/ml SN-50M inactive peptide, abolished
the effect of A1–42 oligomers on CR
post-
mitotic neurons (A1–42 oligomers vs
-RAGE  A1–42 oligomers: p  0.01;
A1–42 oligomers vs JSH-23  A1–42 oli-
gomers: p  0.001; A1–42 oligomers vs
SN-50 A1–42 oligomers: p 0.001; Fig.
6G), MAP-2/nestin immature neurons
(A1–42 oligomers vs -RAGE  A1–42
oligomers: p 0.01; A1–42 oligomers vs JSH-23A1–42 oligom-
ers: p 0.05; A1–42 oligomers vs SN-50 A1–42 oligomers: p
0.01; Fig. 6H), and MAP-2/nestin mature neurons (A1–42 oli-
gomers vs-RAGEA1–42 oligomers:p0.01; A1–42 oligomers
vs JSH-23A1–42 oligomers:p0.01; A1–42 oligomers vs SN-50
A1–42 oligomers:p 0.001; Fig. 6I). No effect was elicited by the
neutralizing antibody or by JSH-23 alone (Fig. 6G–I), whereas, as
reported previously, SN-50 treatment reduced the percentage of
CR and MAP-2/nestin cells in WT NPC cultures (Fig. 6G,I).
To further confirm the role of NF-B signaling pathway activation,
hippocampal NPCs derived from adult p50/ mice and their WT
littermates were differentiated in the presence of 200 nM A1–42
oligomers. As expected, in WT NPCs, A1–42 oligomers increased
the percentage of CR cells (percentage of increase over vehicle-
treated cells:60.4 8.13%; p 0.01), MAP-2/nestin imma-
ture neurons (percentage of increase over vehicle-treated cells:
34.7 1.34%; p 0.01), and MAP-2/nestinmature neurons
(percentage of increase over vehicle-treated cells: 91.1  9.65%;
p 0.001). Conversely, A1–42 oligomers had no effect in p50
/
NPCs (percentage over vehicle-treated cells:2.6 3.72,10.5
Figure5. TgCRND8neural progenitors generate an increasednumberof CRpostmitotic neurons in vitro viaRAGE/NF-Baxis.
A, B, Confocal microscopy images of CR neurons (green) generated in vitro from adult hippocampal NPCs isolated fromWT (A)
and TgCRND8 (B) mice. Nuclei were counterstained with Hoechst (blue). Magnification, 600. Scale bar, 56.25 m. C, D,
TgCRND8 NPCs gave rise to a higher percentage of CR neurons over total viable cells compared withWT NPCs (C) in the absence
of differences in the apoptotic rate (D). Data represent the mean SEM of n 3 experiments, run in triplicates. ***p 0.001
versus WT cultures (Student’s t test). E, F, In the presence of a neutralizing anti-RAGE antibody (E;-RAGE, 20g/ml) or SN-50
peptide (F; 10g/ml) the percentage of CR neurons derived from TgCRND8 NPCs was similar to that ofWT cultures. Treatment
with SN-50 peptide also decreased the percentage of CR neurons in WT cultures compared with vehicle (F ). Data represent the
mean SEMof n 3 experiments, run in triplicates. *p 0.05, **p 0.01 versus vehicle-treatedWT cells (Student’s t test).G,
WTNPCs exposed to TgCRND8NPC-conditionedmedium (Tg) gave rise to a significantly higher percentage of CR cells compared
withWTcells differentiated in thepresenceof standard (std) orWTNPC-conditioned (wt)media.Media switch experiments hadno
effect on neuronal differentiation of TgCRND8 NPC cultures. Data represent the mean SEM of n 3 experiments, run in
triplicates. **p0.01 versusWT cells differentiated in standardmedium(Student’s t test).H, Quantificationof p65nuclei inWT
NPCs after 2 h exposure toWT- or TgCRND8-conditionedmedia. Data are expressed as percentage of p65 nuclei over total p65 IR
cells. **p 0.01 versusWT cells differentiated in standardmedium (Student’s t test). I, Percentage of CR cells inWT NPCs after
24 h exposure toWT- or TgCRND8-conditionedmedia in the presence or absence of JSH-23 (3M). I, Data represent themean
SEM of n 3 experiments, run in triplicates. **p 0.01, ***p 0.001 versus WT-conditioned medium; ##p 0.01 versus
vehicle-treated TgCRND8 medium (Student’s t test).
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6.32, and1.31.27% for CR, MAP-2/nestin, and MAP-2/
nestin cells, respectively). Overall, these data demonstrated that
activation of the RAGE/NF-B axis mediated the proneurogenic
effects elicited by A1–42 oligomers on adult hippocampal NPCs.
The absolute number of newly generated mature neurons is
not significantly different in 32-week-oldWT and TgCRND8
mice hippocampi
Based on the observation that 32-week-old TgCRND8 mice have
an increased number of CR postmitotic neurons, we adminis-
tered BrdU (100 mg/kg, i.p., twice a day for 5 consecutive days) to
WT and TgCRND8 (n 5 per group) of corresponding age and
collected their brains 3 weeks after the last BrdU injection. We
then performed a double immunostaining for BrdU and NeuN (a
marker of mature neurons) on brain sections. BrdU-IR cells from
a set of 1 in 8 sections throughout the hip-
pocampal DG extension of each animal
were analyzed by confocal microscopy
and 3D reconstruction to establish colo-
calization with NeuN. As shown in Figure
7, A, B, and E, as expected, BrdU/
NeuN cells were significantly increased
in the GCL of TgCRND8 compared with
age-matched WT mice (96  40 and
418  290 in WT and Tg mice GCL, re-
spectively; p 0.05). Surprisingly, despite
the presence of a significantly increased
number of DCX progenitors/neuro-
blasts and CR postmitotic neurons, we
documented no significant change in the
number of mature newly generated neu-
rons identified as BrdU/NeuN cells
in the GCL of the two mouse groups
(mean SD number: 146 20 and 154
79 in WT and Tg mice, respectively; Fig.
7C–E).
Discussion
In a recent study, we proposed a novel role
for the RAGE/NF-B axis, namely pro-
motion of neuronal differentiation in
SVZ-derived adult NPCs (Meneghini et
al., 2010). Here we further extend our ob-
servations providing evidence for RAGE
expression in Sox-2hippocampal neural
progenitors in vivo and in vitro. In addi-
tion, we demonstrated that the alarmin
HMGB-1 promoted neuronal differentia-
tion of adult hippocampal neural progen-
itors via RAGE activation. Interestingly,
under the same experimental conditions,
HMGB-1 had no effect on astrogliogen-
esis, oligodendrogenesis, or cell survival.
Activation of the NF-B signaling path-
way appeared to be involved in the pro-
neurogenic effect elicited by HMGB-1,
because it was counteracted by inhibitors
of p50 and p65 nuclear translocation and
IKK2. Additionally, HMGB-1 proneuro-
genic effect was absent in NPC cultures
derived from p50/mice. These data are
in line with previous reports suggesting
the contribution of the NF-B signaling to
the positive regulation of adult neurogen-
esis (Denis-Donini et al., 2005, 2008; Rolls et al., 2007; Meneghini
et al., 2010; Grilli and Meneghini, 2012). Conversely, NF-B sig-
naling, and in particular p65 activation, has also been involved in
the antineurogenic effects of stress (Koo et al., 2010). The fact that
both induction and inhibition of adult neurogenesis may rely on
activation of NF-B signaling is likely to reflect high-level com-
plexity within the pathway. Indeed, NF-B proteins represent a
composite family of transcription factors (p50, p65, p52, c-rel,
relB) whose members can combine to form heterodimers and
homodimers of different composition, which in turn can be dif-
ferentially activated in a given cell type and exert different, even
opposite, functions through different sets of gene target activa-
tion (Grilli and Memo, 1997; Grilli et al., 2003; Bonini et al., 2011;
Grilli and Meneghini, 2012).
Figure 6. A1–42 oligomers promote neuronal differentiation of adult hippocampal NPCs via activation of the RAGE/NF-B
axis. A, Representative image of monomeric (mon), oligomeric (olig), and fibrillary (fib) A1-42 preparations separated onto
Tris–tricine gel and revealed by silver staining.B–D, One hundred to 500 nM A1–42 oligomers significantly increased, compared
with vehicle, the percentage of CR (B), MAP-2/nestin (C), and MAP-2/nestin (D) neurons generated in WT NPC
cultures. A1–42 monomers and fibrils had no positive effect on neuronal differentiation of WT NPCs, with 500 nM A1–42 fibrils
significantly reducing the number of MAP-2/nestinmature neurons in cultures. E, No difference in the number of apoptotic
cells in vehicle-treated andmonomeric, oligomeric, and fibrillary A1–42-treatedWTNPC cultures. F, No difference in LDH activity
released in media was observed between vehicle-treated and 200 nM monomeric, oligomeric, and fibrillary A1–42-treated WT
NPC cultures.G–I, InWT NPCs, the neutralizing anti-RAGE antibody (-RAGE, 20g/ml), SN-50 peptide (10g/ml), and JSH-23
(3 M) prevented the effect of A1–42 oligomers (200 nM) on CR
 (G), MAP-2/nestin (H ), and MAP-2/nestin (I )
neurons. SN-50 alone reduced the percentage of CR (G) and MAP-2/nestin (I ) cells in WT NPC cultures, whereas SN-50M
had no effect alone or in the presence of A1–42 oligomers. B–I, Data represent the mean SEM of n 3 experiments, run in
triplicates. *p 0.05, **p 0.01, ***p 0.001 versus vehicle-treated NPC cultures (Student’s t test).
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There are increasing reports showing that deregulated adult
neurogenesis may be associated with AD (Chuang, 2010; Crews et
al., 2010). Hippocampal neurogenesis and/or proliferation have
been suggested to be increased in AD patients (Jin et al., 2004b).
Data in FAD animal models are mostly contradictory, with both
increased and decreased neurogenesis being described (Chuang,
2010; Crews et al., 2010; Marlatt and Lucassen, 2010). Despite the
paucity of information, relevant therapeutic implications for
modulation of adult hippocampal neurogenesis in AD can be
envisioned because of the functional impact of this process on
synaptic plasticity, learning, and memory (Schaeffer et al., 2009;
Gonzalez-Castaneda et al., 2011; Iqbal and Grundke-Iqbal,
2011). Therefore, research efforts are required for a better under-
standing of the receptors and signals that may regulate hip-
pocampal neurogenesis in AD.
We evaluated hippocampal neurogenesis in TgCRND8 mice,
a FAD animal model characterized by age-related accumulation
of amyloid deposits in cortex, HP, and white matter accompanied
by extensive neuroinflammation and severe cognitive impair-
ment within the first year of life (Chishti et al., 2001; Hyde et al.,
2005). By analyzing the number of BrdU-incorporating cells in
the SGZ and GCL of adult TgCND8 and WT mice 24 h after
administration of the thymidine analog, we observed no signifi-
cant difference in the percentage of IR cells between the two
genotypes at 8 weeks (pre-plaque stage) and 20 weeks (initial
stage of amyloid pathology) of age. Conversely, 32-week-old
TgCRND8 mice had significantly more BrdU-IR cells in the SGZ,
but not in GCL, compared with WT animals, suggesting an in-
creased cell proliferation in the region in which neural stem/
NPCs lie and divide. In the 24 h BrdU paradigm, we could also
observe an increased number of DCX/BrdU cells in the SGZ
of 32-week-old TgCRND8 mice compared with WT littermates,
suggesting an increased proliferation rate of DCX cells in the
AD mouse model. These changes were accompanied by a signif-
icant increase in the number of DCX/BrdU neuroblasts in the
GCL of 32-week-old TgCRND8 compared with WT littermates,
as measured 21 d after BrdU labeling. We propose that these
changes were not merely attributable to increased survival of
BrdU-labeled cells in mutant mice because, in parallel, no signif-
icant difference could be observed in the absolute number of
BrdU cells in hippocampi of TgCRND8 and WT mice at 21 d
after BrdU injection. Finally, we demonstrated that the absolute
number of DCX cells as well as of CR postmitotic adult-born
neurons were significantly increased in the hippocampi of
TgCRND8 mice compared with WT animals. Overall, these re-
sults are in line with data obtained in other APP Tg mouse mod-
els, in which an increased cell proliferation and/or an enhanced
formation of newborn neuroblasts and postmitotic neurons was
observed only at a post-plaque deposition stage (Jin et al., 2004a;
Ermini et al., 2008; Kolecki et al., 2008; Yu et al., 2009).
By using TgCRND8- and WT-derived hippocampal NPCs, we
further investigated the molecular mechanisms potentially in-
volved in the increased number of progenitors, neuroblasts, and
postmitotic neurons in TgCRND8 hippocampi. We demon-
strated that, also in vitro, TgCRND8-derived NPCs had a higher
neurogenic potential compared with WT-derived progenitors
and that this increased effect could be abolished by blocking ac-
tivation of the RAGE/NF-B axis. Additionally, conditioned me-
dia from TgCRND8 NPC cultures also increased the number of
neurons generated in vitro by adult WT NPC cultures, and again,
this effect correlated with NF-B activation and in particular with
p65 nuclear translocation. In an attempt to identify the soluble
factors that were responsible for that effect, we could prove the
presence of human A1– 42 in TgCRND8-conditioned media and
that only A1– 42 oligomers but not monomers or fibrils could act
as proneurogenic signal when added to cultures of adult hip-
pocampal NPCs. These data are in agreement with previous stud-
ies suggesting that oligomeric A can increase the number of
newborn neurons derived from neonatal hippocampal and adult
SVZ neural progenitors (Lo´pez-Toledano and Shelanski, 2004;
Heo et al., 2007). Herein we provide novel evidence that the
proneurogenic effect of A1– 42 oligomers is RAGE mediated and
requires nuclear translocation of NF-B p50/p65 dimers. As
shown for HMGB-1, the proneurogenic effect of oligomeric A
was absent in NPC cultures derived from p50/mice. Although
not conclusive, these data potentially suggest that the activation
Figure 7. Similar numbers of BrdU/NeuN neurons in the DG of 32-week-old TgCRND8 andWTmice. A,B and C,D, Representative confocal microscopy images of BrdU (blue) and NeuN (red)
double immunostaining in DG of 32-week-old WT (A, C) and TgCRND8 (B, D) mice. Arrowheads indicate BrdU/NeuN (A, B) and BrdU/NeuN (C, D) cells. Scale bar, 47.7m. E, Confocal
microscopy and 3D reconstruction analysis revealed a significant increase in the number of BrdU/NeuN cells but no difference in the number of mature BrdU/NeuN neurons in the GCL of
32-week-old TgCRND8 mice compared with age-matched WT littermates. Data represent the mean SD. *p 0.05 versus WTmice (Student’s t test).
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of RAGE/NF-B axis by A oligomers (or by HMGB-1) in adult
NPCs may potentially contribute to the increased number of
DCX and CR cells in hippocampi of TgCRND8 mice. Fur-
thermore, these data corroborate the idea that not all effects elic-
ited by A oligomers in brain are invariably deleterious.
Over the years, extensive research work has contributed to the
concept of RAGE involvement in AD-associated inflammation
and neurodegeneration (Yan et al., 1997; Lue et al., 2001; Arancio
et al., 2004; Deane et al., 2004; Esposito et al., 2008; Takuma et al.,
2009; Fang et al., 2010; Perrone et al., 2012), events that are usu-
ally correlated with the toxic effects of A oligomers rather than
fibrils (Walsh and Selkoe, 2004; Glabe, 2005; Glabe and Kayed
2006). Indeed, several groups have proposed blockade of RAGE
as a strategy for therapeutic intervention in AD (Aderinwale et al.,
2010; Sabbagh et al., 2011; Deane et al., 2012; Perrone et al.,
2012). The novel proneurogenic role of RAGE/NF-B axis acti-
vation adds complexity to that scenario, opening the possibility
that RAGE engagement by HMGB-1, whose expression levels are
increased in AD (Takata et al., 2003), or by A oligomers could
also promote the differentiation of adult hippocampal NPCs to-
ward the neuronal lineage in vivo. In a murine model of traumatic
brain injury, Kleindienst et al. (2005) demonstrated that the pro-
neurogenic effects induced by intracerebroventricular adminis-
tration of the RAGE ligand S100B correlated with improved
cognitive recovery. Conversely, despite the increased number of
DCX neuroblasts and CR postmitotic neurons, TgCRND8
mice are cognitively impaired (Chishti et al., 2001; Hyde et al.,
2005). Indeed, when we extended our analysis to establish the
final destiny of adult-born neurons in 32-week-old TgCRND8
mice, no significant difference could be observed in the absolute
number of mature BrdU/NeuN cells in TgCRND8 and WT
mice hippocampi. These findings potentially suggest that, unlike
acute damage, in a chronic neurodegenerative disease, the
RAGE-mediated hippocampal proneurogenic response is
quantitatively and/or temporally inadequate to counteract
age-progressing pathophysiological events such as amyloid
deposition, neurodegeneration, and/or neuroinflammation.
It could also be envisioned that, in AD pathology, final inte-
gration and/or full maturation of adult generated neurons
may be hampered by a hostile microenvironment (Li et al.,
2008; Schaeffer et al., 2009). Surprisingly, in such respects, A
oligomers are not deleterious but may actually promote dif-
ferentiation of adult NPCs toward the neuronal lineage.
Altogether, our data propose a novel molecular mechanism
that may regulate hippocampal neurogenesis in AD brain and
rely on A oligomers and HMGB-1-induced activation of
RAGE/NF-B axis in adult NPCs. Although this potentially
reparative attempt is not sufficient to attenuate damage and
cognitive impairment, we believe that these findings would
reinforce the need for multitargeted drug strategies in AD.
Ideally, therapeutic interventions should combine the ability
of promoting and sustaining hippocampal neurogenesis as
well as counteracting the hostile brain microenvironment, so
to allow survival and complete maturation/integration of
adult newborn neurons.
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